Cargando…
Diagnostic performance of commercially available COVID-19 serology tests in Brazil
Timely and accurate laboratory testing is essential for managing the global COVID-19 pandemic. Reverse transcription polymerase chain reaction remains the gold-standard for SARS-CoV-2 diagnosis, but several practical issues limit the test’s use. Immunoassays have been indicated as an alternative for...
Autores principales: | Cota, Gláucia, Freire, Mariana Lourenço, de Souza, Carolina Senra, Pedras, Mariana Junqueira, Saliba, Juliana Wilke, Faria, Verônica, Alves, Líndicy Leidicy, Rabello, Ana, Avelar, Daniel Moreira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7544564/ https://www.ncbi.nlm.nih.gov/pubmed/33039612 http://dx.doi.org/10.1016/j.ijid.2020.10.008 |
Ejemplares similares
-
Performance differences among commercially available antigen rapid tests for COVID-19 in Brazil
por: Freire, Mariana Lourenço, et al.
Publicado: (2022) -
Performance of serological tests available in Brazil for the diagnosis of human visceral leishmaniasis
por: Freire, Mariana Lourenço, et al.
Publicado: (2019) -
The cure rate after different treatments for mucosal leishmaniasis in the Americas: A systematic review
por: Carvalho, Janaína de Pina, et al.
Publicado: (2022) -
Evaluation of a new brand of immunochromatographic test for visceral leishmaniasis in Brazil made available from 2018
por: Freire, Mariana Lourenço, et al.
Publicado: (2018) -
Cost-effectiveness of serological tests for human visceral leishmaniasis in the Brazilian scenario
por: Freire, Mariana Lourenço, et al.
Publicado: (2020)